From: Serum macrophage migration inhibitory factor levels in Hashimoto’s thyroiditis; a case control study
Variable | Group 1 | Group 2 | Group 3 | Group 4 | p |
---|---|---|---|---|---|
(n = 52) | (n = 31) | (n = 10) | (n = 53) | ||
Age (years) | 30.7 ± 9.9 | 30.1 ± 10 | 38 ± 17.6 | 29.3 ± 8.5 | 0.702* |
Gender (F/M) | 47/5 | 28/3 | 8/2 | 83% | 0.572** |
FT3 (pg/ml) | 3.1 ± 0.2 | 3.1 ± 0.3 | 3.1 ± 0.4 | 3.2 ± 0.3 | 0.252* |
FT4 (ng/dl) | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.8 ± 0.1 | 1.09 ± 0.12 | <0.001* |
TSH (μIU/ml) | 2.3 ± 1.1 | 6.7 ± 1.6 | 23.6 ± 27.2 | 1.8 ± 0.9 | <0.001* |
TGAb (uIU/ml) | 225.5 ± 281.4 | 239.5 ± 319.4 | 229.8 ± 248.1 | 1.7 ± 1.5 | <0.001* |
TPOAb (uIU/ml) | 221.8 ± 361.4 | 386.7 ± 376.5 | 629.8 ± 464.1 | 0.7 ± 3 | <0.001* |
MIF(pg/ml) | 3955.2 ± 3013.6 | 4599.8 ± 2717.9 | 6300.9 ± 2504.3 | 4971.2 ± 3054.4 | 0.044* |